Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUMA Study: Influence of flumazenil on pediatric emergence delirium after ENT surgery
2025-523543-36-00Phase 4Authorised
- Sponsor
- University of Bonn
- Start
- Jan 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of flumazenil in Emergence agitation (EA), sponsored by University of Bonn. Primary endpoint: Incidence of pediatric emergence delirium until discharge from recovery room. Planned start Jan 2026; status: authorised.
02
Drugs
flumazenil
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on 2025-523543-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523543-36-00.